Healthcare
Raffles Medical Group Ltd(RAFLF)
Live Price
Offline$0.80
+0.00% today
1Y Change
+33.33%
Window
Jun 23, 2025 โ Jun 11, 2026
- Market Cap
- $1.83B
- Revenue Growth
- +1.8%
- EPS Growth
- +13.7%
- Dividend Yield
- 2.5%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Raffles Medical Group Ltd (RAFLF) is a Healthcare stock with a market cap of $1.83B and listed on OTC. The stock last traded around $0.80 and up 33.3% across the available one-year price window (Jun 23, 2025 โ Jun 11, 2026). Baseline metrics include revenue growth of +1.8%, EPS growth of +13.7%, a dividend yield of 2.5%. What stands out right now is revenue +1.8%, EPS +13.7%, free cash flow +50.0% with operating margin 10.9% and ROIC 3.9%. The dividend matters to the case here, with a current yield around 2.5%. Valuation already assumes a fairly strong business story at P/E 38.6 and price/sales 3.2. Stock Foundry combines RAFLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.8% vs +7.6% peer median
Operating Margin
Below sector median
+10.9% vs +19.4% peer median
P/E
Above sector median
38.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report was closer to in-line
2026 was reported on Feb 23, 2026 with revenue ahead of estimates by +43.7%.
The operating story is still moving forward
Revenue is running at +1.8% and EPS at +13.7%, with operating margin around 10.9%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 3, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +8.3% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 23, 2026 | โ | +0.0% | +0.0% | +8.1% |
2025 Jul 28, 2025 | โ | +0.0% | +0.0% | -1.2% |
2025 Apr 25, 2025 | โ | +0.0% | +25.0% | +25.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RAFLF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RAFLF Max Drawdown
-13.25%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RAFLF and SPY.
Company Overview
Raffles Medical Group Ltd
Other OTC
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte. Ltd.
- Leadership
- Choon Yong Loo
- IPO Date
- Feb 13, 2009
- Employees
- 3.0k
- Street Address
- 585 North Bridge Road
- Mailing
- Singapore, 188770
- Region
- Singapore, SG
- Reporting Currency
- USD
- Investor Line
- 65 6311 1111
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 38.6
- EV/EBITDA
- 17.9
- Price/Sales
- 3.2
- Price/Book
- 1.7
Growth
- Revenue
- +1.8%
- EPS
- +13.7%
- Free Cash Flow
- +50.0%
Profitability
- Gross Margin
- 45.7%
- Operating Margin
- 10.9%
- Net Margin
- 8.4%
- ROE
- 4.6%
- ROIC
- 3.9%
Balance Sheet
- Debt/Equity
- 0.08
- Current Ratio
- 1.31
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.